Clearside Biomedical Inc logo

Clearside Biomedical Inc

NEW
NAS:CLSD (USA)  
$ 1.02 -0.02 (-1.92%) 07:08 PM EST
At Loss
Market Cap:
$ 76.24M
Enterprise V:
$ 49.61M
Volume:
556.56K
Avg Vol (2M):
996.65K
Trade In:
Volume:
556.56K
At Loss
Avg Vol (2M):
996.65K

Business Description

Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 34.02
Equity-to-Asset -0.83
Debt-to-Equity -0.03
Debt-to-EBITDA -0.04
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -14.53
Distress
Grey
Safe
Beneish M-Score -2.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.26
9-Day RSI 34.97
14-Day RSI 39.86
6-1 Month Momentum % 0.79
12-1 Month Momentum % 75.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.07
Quick Ratio 5.07
Cash Ratio 5
Days Sales Outstanding 21.13
Days Payable 4573.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.6
Shareholder Yield % -19.56

Financials (Next Earnings Date:2024-11-13 Est.)

CLSD's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CLSD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Clearside Biomedical Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.524
EPS (TTM) ($) -0.5
Beta 1.93
Volatility % 62.11
14-Day RSI 39.86
14-Day ATR ($) 0.108342
20-Day SMA ($) 1.22325
12-1 Month Momentum % 75.27
52-Week Range ($) 0.7564 - 2.12
Shares Outstanding (Mil) 74.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clearside Biomedical Inc Filings

Filing Date Document Date Form
No Filing Data

Clearside Biomedical Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Clearside Biomedical Inc Frequently Asked Questions

What is Clearside Biomedical Inc(CLSD)'s stock price today?
The current price of CLSD is $1.02. The 52 week high of CLSD is $2.12 and 52 week low is $0.76.
When is next earnings date of Clearside Biomedical Inc(CLSD)?
The next earnings date of Clearside Biomedical Inc(CLSD) is 2024-11-13 Est..
Does Clearside Biomedical Inc(CLSD) pay dividends? If so, how much?
Clearside Biomedical Inc(CLSD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1